1Shargorodsky J, Curhan GC, Farwell WR (2010) Prevalence and characteristics of tinnitus among US adults. Am J Med 123: 711-718.

2Baguley D, McFerran D, Hall D (2013) Tinnitus. The Lancet 382: 1600-1607.

3Maes IH, Cima RF, Vlaeyen JW, Anteunis LJ, Joore MA (2013) Tinnitus: A Cost Study. Ear Hear 34: 508-514.

4Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, et al. (2010) Ringing in the ears: The neuroscience of tinnitus. J. Neurosci 30: 14972-14979.

5Moller AR (2000) Similarities between severe tinnitus and chronic pain. J Am Acad Audiol 11: 115 – 124.

6Moller AR (2003) Pathophysiology of tinnitus. Otolaryngol Clin North Am 36: 249–266.

7Middleton JW, Kiritani T, Pedersen C, Turner JG, Shepherd GM, et al. (2011) Mice with behavioral evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity because of decreased GABAergic inhibition. Proc Natl Acad Sci U S A 108: 7601-7606.

8Hoekstra CE, Rynja SP, van Zanten GA, Rovers MM (2011) Anticonvulsants for tinnitus. Cochrane Database Syst Rev (7): CD007960.

9Kempel P, Lampe K, Parnefjord R, Hennig J, Kunert HJ (2003) Auditory-evoked potentials and selective attention: Different ways of information processing in Cannabis users and controls. Neuropsychobiol 48: 95-101.

10Hajós M, Hoffmann WE, Kocsis B (2008) Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: Relevance to schizophrenia. Biol Psychiatry 63: 1075-1083.

11Limebeer CL, Rock EM, Mechoulam R, Parker LA. (2012) The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex. Br J Pharmacol 167: 1126-1136.

12Haney M, Rabkin J, Gunderson E, Foltin RW (2005) Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacol (Berl) 181: 170-178.

13Wade DT, Makela PM, House H, Bateman C, Robson P (2006) Long-term use of a cannabis based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Multiple Sclerosis 12: 639-645.

14Gordon E, Devinsky O (2001) Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy. Epilepsia 42:1266-1272.

15Lutz B (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68: 1691-1698.

16Zagnoni PG, Albano C (2002) Psychostimulants and epilepsy. Epilepsia 43: 28-31.

17Lorenz R (2004) On the application of cannabis in paediatrics and epileptology. Neuro Endocrinol Lett 25: 40-44.

18Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160: 467-479.

19Baek JH., Zheng Y, Darlington CL., Smith PF, Ashton JC (2013) Testing antibodies for immunohistochemistry: Brain immunolabelling for the cannabinoid CB2 receptor. J Neurosci Meth 216: 87-95.

20Alger BE (2002) Retrograde signalling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68: 247-286.

21Kreitzer AC, Regehr WG (2002) Retrograde signalling by endocannabinoids. Curr Opin Neurobiol 12: 324-330.

22Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307: 129-137.

23Muccioli, GG, Lamb DM (2005) Current knowledge on antagonists and inverse agonists of cannabinoid receptors. Curr Med Chem 12: 1361-1394.

24Shafaroodi H, Samini M, Moezi L, Homayoun H, Sadeghipour H, et al. (2004) The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 47: 390-400.

25Wallace MJ, Martin BR, DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452: 295-301.

26Hoffman AF, Lupica CR (2000) Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20: 2470-2479.

27Nakatsuka T, Chen HX, Roper SN, Gu JG (2003) Cannabinoid receptor-1 activation suppresses inhibitory synaptic activity in human dentate gyrus. Neuropharmacol 45: 116-121.

28Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, et al. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11: 563-583.

29Breivogel CS, Sim LJ, Childers SR (1997) Regional differences in cannabinoid receptor/G protein coupling in rat brain. J Pharmacol Exp Ther 282: 1632-1642.

30Zheng Y, Baek JH, Smith PF, Darlington CL (2007) Cannabinoid receptor down-regulation in the ventral cochlear nucleus in an animal model of tinnitus. Hear Res 228: 105-111.

31Tzounopoulos T, Rubio ME, Keen JE, Trussell LO (2007) Coactivation of pre- and post-synaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity. Neuron 54: 291-301.

32Ashton JC, Zheng Y, Liu P, Darlington CL, Smith PF (2004) Immunohistochemical characterization and localization of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and effects of unilateral vestibular deafferentation. Brain Res 1021: 266-273.

33Mikasova L, Groc L, Choquet D, Manzoni OJ (2008) Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc Natl Acad Sci U S A 105: 18596-18601.

34Baek JH, Zheng Y, Darlington CL, Smith PF (2008) Cannabinoid CB2 receptor expression in the vestibular and cochlear nuclei. Acta Otolaryngol 128: 961-967.

35Zhao Y, Rubio ME, Tzounopoulos T (2009) Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem. J Neurophysiol 101: 2434-2446.

36De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: A general review and latest additions. Br J Pharmacol 141: 765-774.

37Tzounopoulos T (2008) Mechanisms of synaptic plasticity in the dorsal cochlear nucleus: Plasticity-induced changes that could underlie tinnitus. Am J Audiol 17: S170-S175.

38Sedlacek M, Tipton PW, Brenowitz SD (2011) Sustained firing of cartwheel cells in the dorsal cochlear nucleus evokes endocannabinoid release and retrograde suppression of parallel fiber synapses. J Neurosci 31: 15807-15817.

39Zhao Y, Tzounopoulos T (2011) Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling. J Neurosci 31: 3158-3168.

40Jastreboff PJ, Brennan JF, Coleman JK, Sasaki CT (1988) Phantom auditory sensation in rats: an animal model of tinnitus. Behav Neurosci 102: 811–822.

41Raby WN, Modica PA, Wolintz RJ, Murtaugh K (2006) Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension: a case report. J Ocul Pharmacol Ther 22: 68-75.

42Zheng Y, Stiles L, Hamilton E, Smith PF, Darlington CL (2010) Effects of the synthetic cannabinoid receptor agonists WIN55,212 and CP55940 on salicylate-induced tinnitus in rats. Hear Res 268: 145-150.

43Zhao Y, Rubio M, Tzounopoulos T (2011) Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus. Hear Res 279: 67-73.